Literature DB >> 15116632

Osteoporotic femoral neck fractures: management and current controversies.

Michael J Gardner1, Dean G Lorich, Joseph M Lane.   

Abstract

Osteoporosis is a pervasive disease among the growing elderly population. Femoral neck fractures are often a direct result of osteoporosis and are challenging to treat. Surgical interventions seek to return the patient to preinjury function as quickly as possible, but many obstacles exist. Disruption of the blood supply occurs regardless of the fracture pattern, and in the active elderly population, reduction and fixation should be done as soon as possible to minimize healing problems. Closed reduction with percutaneous cannulated screw instrumentation is currently the fixation method of choice, but even with meticulous technique, moderate complication rates persist. Newer devices and biologic bone augmentation cement show promise in decreasing postoperative fracture collapse. Patients in whom a stable reduction cannot be achieved or who have a limited life expectancy should undergo arthroplasty. Unipolar and bipolar arthroplasty have both been effective in restoring function and have been the standard of care in these patients. Recent evidence suggests that active elderly patients who have acetabular disease or severely displaced fractures may benefit most from primary total hip arthroplasty.

Entities:  

Mesh:

Year:  2004        PMID: 15116632

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  9 in total

1.  Role of Supplemental Teriparatide Therapy to Augment Functional and Radiological Outcomes in Osteoporotic Intertrochanteric Hip Fractures in the Elderly Population.

Authors:  Sanket Mishra; Deepankar Satapathy; Sidhartha Samal; Nego Zion; Udeepto Lodh
Journal:  Cureus       Date:  2022-06-22

2.  Role of supplemental teriparatide therapy in management of osteoporotic intertrochanteric femur fractures.

Authors:  Anurag Rana; Sameer Aggarwal; Vikas Bachhal; Aman Hooda; Karan Jindal; Mandeep Singh Dhillon
Journal:  Int J Burns Trauma       Date:  2021-06-15

3.  Risk of bony violation with standard triple screw configurations for fixation of femoral neck fractures: A preliminary computed tomography based analysis.

Authors:  Vivek Trikha; Arvind Kumar; Samarth Mittal; Jigyasa Passey; Dushyant Chouhan; Siddharth Dubey
Journal:  J Clin Orthop Trauma       Date:  2020-05-05

Review 4.  Cement augmentation for trochanteric fracture in elderly: A systematic review.

Authors:  Leonardo Stramazzo; Salvatore Ratano; Francesco Monachino; Davide Pavan; Giuseppe Rovere; Lawrence Camarda
Journal:  J Clin Orthop Trauma       Date:  2020-10-20

5.  Alumina-on-alumina total hip replacement for femoral neck fracture in healthy patients.

Authors:  Giuseppe Solarino; Andrea Piazzolla; Claudio M Mori; Lorenzo Moretti; Silvio Patella; Angela Notarnicola
Journal:  BMC Musculoskelet Disord       Date:  2011-02-01       Impact factor: 2.362

6.  Retrospective evaluation of bipolar hip arthroplasty in fractures of the proximal femur.

Authors:  Sakr Mazen; Girard Julien; Fakih Riad
Journal:  N Am J Med Sci       Date:  2010-09

7.  Effect of teriparatide on unstable pertrochanteric fractures.

Authors:  Tsan-Wen Huang; Tien-Yu Yang; Kuo-Chin Huang; Kuo-Ti Peng; Mel S Lee; Robert Wen-Wei Hsu
Journal:  Biomed Res Int       Date:  2015-02-10       Impact factor: 3.411

8.  Association of Osteoporosis Self-Assessment Tool for Asians (OSTA) Score with Clinical Presentation and Expenditure in Hospitalized Trauma Patients with Femoral Fractures.

Authors:  Chien-Chang Chen; Cheng-Shyuan Rau; Shao-Chun Wu; Pao-Jen Kuo; Yi-Chun Chen; Hsiao-Yun Hsieh; Ching-Hua Hsieh
Journal:  Int J Environ Res Public Health       Date:  2016-10-10       Impact factor: 3.390

9.  The effects of bone-substitute augmentation on treatment of osteoporotic intertrochanteric fractures.

Authors:  Fu-Chun Chang; Pao-Yao Chuang; Ching-Yu Lee; Chien-Yin Lee; Ying-Chao Chou; Tsan-Wen Huang; Kuo-Chin Huang; Hsin-Nung Shih; Mel S Lee
Journal:  Biomed J       Date:  2020-05-23       Impact factor: 7.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.